Connect your AI

OS Therapies OSTX Accounts payable and other current liabilities (Note 11)

Accounts payable and other current liabilities (Note 11) at other companies

T-Mobile USTMUS

$9.52B+20.5%

Nasdaq, Inc.NDAQ

$245M-3.9%

UnitedHealth GroupUNH

$38.63B+15.1%

Freeport-McMoRan Inc.FCX

$4.14B+1.6%

Equinix, Inc.EQIX

$1.32B+19.5%

Robinhood Markets, Inc.HOOD

$522M+63.6%

Other financials

Income statement

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's accounts payable and other current liabilities (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OS Therapies's accounts payable and other current liabilities (note 11)?: OS Therapies (OSTX) reported accounts payable and other current liabilities (note 11) of $15.23M in Q1 2026.